Literature DB >> 19850683

Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency.

Emanuele Miraglia del Giudice1, Nicola Santoro, Alessandra Amato, Carmine Brienza, Paolo Calabrò, Erwin T Wiegerinck, Grazia Cirillo, Nunzia Tartaglione, Anna Grandone, Dorine W Swinkels, Laura Perrone.   

Abstract

CONTEXT: Obesity and iron deficiency are two of the most common nutritional disorders worldwide. Several studies found higher rates of iron deficiency in obese than in normal-weight children. Hepcidin represents the main inhibitor of intestinal iron absorption, and its expression is increased in adipose tissue of obese patients. Leptin is able, in vitro, to raise hepcidin expression.
OBJECTIVES: Aims of this work were 1) to assess the association between poor iron status and obesity, 2) to investigate whether iron homeostasis of obese children may be modulated by serum hepcidin variations, and 3) to assess the potential correlation between leptin and serum hepcidin variations.
METHODS: Iron status and absorption as well as hepcidin, leptin, and IL-6 levels were studied in 60 obese children and in 50 controls.
RESULTS: Obese children showed lower iron and transferrin saturation (both P < 0.05) and higher hepcidin levels (P = 0.004) compared with controls. A direct correlation between hepcidin and obesity degree (P = 0.0015), and inverse correlations between hepcidin and iron (P = 0.04), hepcidin and transferrin saturation (P = 0.005), and hepcidin and iron absorption (P = 0.003) were observed. A correlation between leptin and hepcidin (P = 0.006) has been found. The correlation remained significant when adjusted for body mass index, sex, pubertal stage, and IL-6 values.
CONCLUSIONS: We propose that in obese patients, increased hepcidin production, at least partly leptin mediated, represents the missing link between obesity and disrupted iron metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850683     DOI: 10.1210/jc.2009-1361

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  54 in total

Review 1.  Iron and immunity: immunological consequences of iron deficiency and overload.

Authors:  Bobby J Cherayil
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-09-28       Impact factor: 4.291

2.  Immunoassay-based serum hepcidin reference range measurements in healthy children: differences among age groups.

Authors:  Triantafyllia Sdogou; Charalampos Tsentidis; Dimitrios Gourgiotis; Antonios Marmarinos; Alexandra Gkourogianni; Ioannis Papassotiriou; Theodora Anastasiou; Lydia Kossiva
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

3.  Serum hepcidin levels and iron metabolism in obese children with and without fatty liver: case-control study.

Authors:  Fatih Demircioğlu; Gökhan Görünmez; Emine Dağıstan; Sevil Bilir Göksügür; Mervan Bekdaş; Mehmet Tosun; Betül Kızıldağ; Erol Kısmet
Journal:  Eur J Pediatr       Date:  2014-02-07       Impact factor: 3.183

4.  Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.

Authors:  Ho-Chang Kuo; Ya-Ling Yang; Jiin-Haur Chuang; Mao-Meng Tiao; Hong-Ren Yu; Li-Tung Huang; Kuender D Yang; Wei-Chiao Chang; Chiu-Ping Lee; Ying-Hsien Huang
Journal:  J Clin Immunol       Date:  2012-03-06       Impact factor: 8.317

5.  Prepregnancy Body Mass Index and Gestational Weight Gain Have No Negative Impact on Maternal or Neonatal Iron Status.

Authors:  Chang Cao; Eva K Pressman; Elizabeth M Cooper; Ronnie Guillet; Mark Westerman; Kimberly O O'Brien
Journal:  Reprod Sci       Date:  2015-09-29       Impact factor: 3.060

Review 6.  Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin.

Authors:  Lisa Tussing-Humphreys; Cenk Pusatcioglu; Cenk Pustacioglu; Elizabeta Nemeth; Carol Braunschweig
Journal:  J Acad Nutr Diet       Date:  2012-03-01       Impact factor: 4.910

7.  Iron deficiency in pediatric patients in long-term risperidone treatment.

Authors:  Chadi Albert Calarge; Ekhard E Ziegler
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03-12       Impact factor: 2.576

8.  Study of Serum Hepcidin as a Potential Mediator of the Disrupted Iron Metabolism in Obese Adolescents.

Authors:  Hayam K Nazif; Azza Abd El-Shaheed; Karima A I El-Shamy; Manal A Mohsen; Nevein N Fadl; Rehab S I Moustafa
Journal:  Int J Health Sci (Qassim)       Date:  2015-04

Review 9.  A review of iron studies in overweight and obese children and adolescents: a double burden in the young?

Authors:  Carol Hutchinson
Journal:  Eur J Nutr       Date:  2016-02-16       Impact factor: 5.614

10.  The effect of central obesity on inflammation, hepcidin, and iron metabolism in young women.

Authors:  Nicole U Stoffel; Carla El-Mallah; Isabelle Herter-Aeberli; Nour Bissani; Nour Wehbe; Omar Obeid; Michael B Zimmermann
Journal:  Int J Obes (Lond)       Date:  2020-01-23       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.